|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
Sec Filings Insider Trading - Altus Pharmaceuticals Inc. (ALTU)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |
Altus Pharmaceuticals Inc: Insider Trading and Stock Options
Common stock purchase or sale:
| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2009-09-14 Sale |
2009-09-16 8:49 pm | Altus Pharmaceuticals Inc. | ALTU | PRESIDIO MANAGEMENT GROUP VIII L L C ROOT JONATHAN D Rust Christopher J YOUNG PHILIP M (10% owner) | 300,000 | $0.3243 | $97,290 | 13,306 (Indirect) |
View |
| 2009-09-14 Sale | 2009-09-16 8:48 pm | Altus Pharmaceuticals Inc. | ALTU | PRESIDIO MANAGEMENT GROUP VIII L L C US VENTURE PARTNERS VIII L P USVP VIII AFFILIATES FUND L P USVP ENTREPRENEUR PARTNERS VIII A L P USVP ENTREPRENEUR PARTNERS VIII B L P Connors Timothy J FEDERMAN IRWIN FU WINSTON S KRAUSZ STEVEN M LIDDLE DAVID E (10% owner) | 300,000 | $0.3243 | $97,290 | 13,306 (Indirect) |
View |
| 2009-04-16- -2009-04-20 Sale |
2009-04-20 5:21 pm | Altus Pharmaceuticals Inc. | ALTU | WARBURG PINCUS PRIVATE EQUITY VIII L P Warburg Pincus Partners LLC WARBURG PINCUS LLC WARBURG PINCUS & CO (10% owner) | 785,122 | $0.2077 | $163,054 | 1,784,948 (Direct) | View |
| 2009-04-13- -2009-04-15 Sale | 2009-04-15 5:21 pm | Altus Pharmaceuticals Inc. | ALTU | WARBURG PINCUS PRIVATE EQUITY VIII L P Warburg Pincus Partners LLC WARBURG PINCUS LLC WARBURG PINCUS & CO (10% owner) | 358,473 | $0.2117 | $75,893 | 2,570,070 (Direct) |
View |
| 2009-04-07- -2009-04-09 Sale |
2009-04-09 5:23 pm | Altus Pharmaceuticals Inc. | ALTU | WARBURG PINCUS PRIVATE EQUITY VIII L P Warburg Pincus Partners LLC WARBURG PINCUS & CO WARBURG PINCUS LLC (10% owner) | 660,703 | $0.2181 | $144,094 | 2,928,543 (Direct) |
View |
| 2007-07-18 Sale | 2007-07-20 3:31 pm | Altus Pharmaceuticals Inc. | ALTU | Margolin Alexey L (Chief Scientific Officer) | 10,900 | $11.55 | $125,895 | 135,204 (Direct) | View |
| 2006-07-31 Sale | 2006-08-02 12:43 pm | Altus Pharmaceuticals Inc. | ALTU | VERTEX PHARMACEUTICALS INC (10% owner) | 817,749 | $14.28 | $11,677,456 | 0 (Direct) |
View |
Other transactions:
| Transaction & Date | Reported Date | Company | Symbol | Insider Relationship | Shares Traded |
Average Price |
Total Amount |
Shares Ownership | Filing |
| 2007-12-13 Exercise | 2007-12-14 08:16 am |
Altus Pharmaceuticals Inc. | ALTU | Berkle Sheldon (President and CEO Director) | 32,000 | $3.92 | $125,440 | 40,000 (Direct) |
View |
| 2006-01-31 Other Purchase(A) |
2006-11-15 4:03 pm | Altus Pharmaceuticals Inc. | ALTU | NOMURA INTERNATIONAL PLC Nomura Phase4 Ventures LP Nomura Phase4 Ventures LTD Nomura Phase4 Ventures GP LTD (Shareholder) | 1,746,463 | $0 | $0 | 552,227 (Direct Indirect) |
View |
| 2006-01-31 Purchase |
2006-02-02 7:34 pm |
Altus Pharmaceuticals Inc. | ALTU | BRUM LYNNE H (Director) | 381,596 | $0 | $0 | 817,749 (Indirect) |
View |
| 2006-01-31 Other Purchase |
2006-02-01 4:05 pm | Altus Pharmaceuticals Inc. | ALTU | NOMURA INTERNATIONAL PLC Nomura Phase4 Ventures LP (10% owner) | 1,746,463 | $0 | $0 | 552,263 (Direct Indirect) | View |
(A) Indicate amendment filing.
Stock options: Exercise, Award, Grant, Conversion
| Transaction & Date |
Reported Date |
Exercisable Expiration | Company | Symbol | Insider Relationship |
Shares Traded | Conversion Price |
Shares Ownership |
Filing |
| 2009-07-01 Option Award |
2009-07-02 12:01 pm | N/A 2019-07-01 |
Altus Pharmaceuticals Inc. | ALTU | WYZGA MICHAEL S (Director) | 10,903 | $0.43 | 10,903 (Direct) | View |
| 2009-07-01 Option Award |
2009-07-02 12:00 pm | N/A 2019-07-01 |
Altus Pharmaceuticals Inc. | ALTU | PENNER HARRY JR (Director) | 11,993 | $0.43 | 11,993 (Direct) | View |
| 2009-07-01 Option Award | 2009-07-02 11:59 am | N/A 2019-07-01 | Altus Pharmaceuticals Inc. | ALTU | NAVIA MANUEL (Director) | 14,173 | $0.43 | 14,173 (Direct) | View |
| 2009-07-01 Option Award |
2009-07-02 11:58 am | N/A 2019-07-01 |
Altus Pharmaceuticals Inc. | ALTU | Richard John P (Director) | 9,812 | $0.43 | 9,812 (Direct) | View |
| 2009-07-01 Option Award |
2009-07-02 11:54 am | N/A 2019-07-01 | Altus Pharmaceuticals Inc. | ALTU | PENDERGAST DAVID D PHD (Director) | 11,993 | $0.43 | 11,993 (Direct) |
View |
| 2009-01-27 Option Award | 2009-02-23 09:06 am | N/A 2019-01-27 |
Altus Pharmaceuticals Inc. | ALTU | GEMAYEL GEORGES (President & CEO Director) | 560,000 | $0.22 | 560,000 (Direct) | View |
| 2009-02-19 Option Sale | 2009-02-23 09:05 am |
N/A 2018-06-02 | Altus Pharmaceuticals Inc. | ALTU | GEMAYEL GEORGES (President & CEO Director) | 440,000 | $4.07 | 120,000 (Direct) |
View |
| 2009-02-19 Option Award | 2009-02-23 09:05 am | N/A 2018-06-02 | Altus Pharmaceuticals Inc. | ALTU | GEMAYEL GEORGES (President & CEO Director) | 440,000 | $0.19 | 440,000 (Direct) | View |
| 2009-01-27 Option Award |
2009-01-29 4:22 pm | N/A 2019-01-27 | Altus Pharmaceuticals Inc. | ALTU | Phair Thomas J. (Sr. Dir, Finance & Controller) | 250,000 | $0.22 | 250,000 (Direct) | View |
| 2009-01-27 Option Award |
2009-01-29 4:21 pm |
N/A 2019-01-27 |
Altus Pharmaceuticals Inc. | ALTU | Porter Jill (VP, Process Dev & Engineering) | 250,000 | $0.22 | 250,000 (Direct) |
View |
| 2009-01-27 Option Award |
2009-01-29 4:20 pm |
N/A 2019-01-27 | Altus Pharmaceuticals Inc. | ALTU | Attie Kenneth (VP, Clinical Dev & Med Affairs) | 250,000 | $0.22 | 250,000 (Direct) |
View |
| 2009-01-27 Option Award | 2009-01-29 4:20 pm | N/A 2019-01-27 | Altus Pharmaceuticals Inc. | ALTU | Gotwals Philip (VP, Program Management) | 250,000 | $0.22 | 250,000 (Direct) |
View |
| 2009-01-27 Option Award | 2009-01-29 4:19 pm |
N/A 2019-01-27 | Altus Pharmaceuticals Inc. | ALTU | GEMAYEL GEORGES (President & CEO Director) | 1,000,000 | $0.22 | 1,000,000 (Direct) |
View |
| 2008-06-12 Option Award | 2008-06-13 5:03 pm | 2008-06-12 2018-06-12 |
Altus Pharmaceuticals Inc. | ALTU | ROOT JONATHAN D (Director 10% owner) | 8,722 | $3.93 | 39,318 (Direct) |
View |
| 2008-06-12 Option Award |
2008-06-13 5:03 pm |
2008-06-12 2018-06-12 | Altus Pharmaceuticals Inc. | ALTU | ROOT JONATHAN D (Director 10% owner) | 2,181 | $3.93 | 41,499 (Direct) | View |
| 2008-06-12 Option Award | 2008-06-13 08:47 am | N/A 2018-06-12 | Altus Pharmaceuticals Inc. | ALTU | PENDERGAST DAVID D PHD (Executive Chairman Director) | 15,274 | $3.93 | 15,274 (Direct) |
View |
| 2008-06-12 Option Award | 2008-06-13 08:39 am | N/A 2018-06-12 | Altus Pharmaceuticals Inc. | ALTU | WYZGA MICHAEL S (Director) | 10,903 | $3.93 | 10,903 (Direct) |
View |
| 2008-06-12 Option Award | 2008-06-13 08:37 am | N/A 2018-06-12 |
Altus Pharmaceuticals Inc. | ALTU | PENNER HARRY JR (Director) | 11,993 | $3.93 | 11,993 (Direct) |
View |
| 2008-06-12 Option Award | 2008-06-13 08:35 am | N/A 2018-06-12 |
Altus Pharmaceuticals Inc. | ALTU | NAVIA MANUEL (Director) | 10,902 | $3.93 | 10,902 (Direct) | View |
| 2008-06-12 Option Award |
2008-06-13 08:34 am | N/A 2018-06-12 | Altus Pharmaceuticals Inc. | ALTU | LEFF JONATHAN S (Director 10% owner) | 8,722 | $3.93 | 8,722 (Direct) |
View |
| 2008-06-12 Option Award |
2008-06-13 08:33 am |
N/A 2018-06-12 | Altus Pharmaceuticals Inc. | ALTU | HEN STEWART (Director 10% owner) | 10,903 | $3.93 | 10,903 (Direct) | View |
| 2008-06-12 Option Award |
2008-06-13 08:32 am | N/A 2018-06-12 | Altus Pharmaceuticals Inc. | ALTU | Richard John P (Director) | 9,812 | $3.93 | 9,812 (Direct) | View |
| 2008-06-02 Option Award | 2008-06-03 08:36 am |
N/A 2018-06-02 | Altus Pharmaceuticals Inc. | ALTU | GEMAYEL GEORGES (President & CEO Director) | 560,000 | $4.07 | 560,000 (Direct) | View |
| 2008-06-02 Option Award | 2008-06-03 08:36 am | N/A 2018-06-02 |
Altus Pharmaceuticals Inc. | ALTU | GEMAYEL GEORGES (President & CEO Director) | 340,000 | $4.07 | 340,000 (Direct) | View |
| 2008-05-22 Option Award |
2008-05-27 4:13 pm |
N/A 2018-05-22 |
Altus Pharmaceuticals Inc. | ALTU | Lieber Jonathan I (SVP, CFO and Treasurer) | 45,000 | $4.41 | 45,000 (Direct) | View |
| 2008-05-22 Option Award | 2008-05-27 4:11 pm |
N/A 2018-05-22 |
Altus Pharmaceuticals Inc. | ALTU | BLANK BURKHARD (EVP & Chief Medical Officer) | 12,500 | $4.41 | 12,500 (Direct) | View |
| 2008-02-25 Option Award |
2008-02-27 4:28 pm | N/A 2018-02-25 | Altus Pharmaceuticals Inc. | ALTU | Sorvillo John M (VP, Business Development) | 17,500 | $5.72 | 17,500 (Direct) |
View |
| 2008-02-25 Option Award | 2008-02-27 4:27 pm | N/A 2018-02-25 |
Altus Pharmaceuticals Inc. | ALTU | Sabella Lauren M (VP of Commercial Development) | 17,500 | $5.72 | 17,500 (Direct) |
View |
| 2008-02-25 Option Award | 2008-02-27 4:26 pm |
N/A 2018-02-25 | Altus Pharmaceuticals Inc. | ALTU | Lieber Jonathan I (VP, CFO and Treasurer) | 28,000 | $5.72 | 28,000 (Direct) | View |
| 2008-02-25 Option Award |
2008-02-27 4:24 pm |
N/A 2018-02-25 |
Altus Pharmaceuticals Inc. | ALTU | Gallotto Robert (VP, Strategic Planning) | 17,500 | $5.72 | 17,500 (Direct) |
View |
| 2008-02-25 Option Award | 2008-02-27 4:23 pm | N/A 2018-02-25 |
Altus Pharmaceuticals Inc. | ALTU | Leicher Bruce (Sr VP Gen Counsel & Secretary) | 28,000 | $5.72 | 28,000 (Direct) | View |
| 2007-12-13 Exercise |
2007-12-14 08:16 am | 2005-05-09 2015-05-08 | Altus Pharmaceuticals Inc. | ALTU | Berkle Sheldon (President and CEO Director) | 32,000 | $3.92 | 439,152 (Direct) |
View |
| 2007-05-01 Option Award |
2007-05-02 3:17 pm | 2007-05-01 2012-05-01 |
Altus Pharmaceuticals Inc. | ALTU | FUCHS RENATO (SVP, Manufacturing & Tech Ops) | 40,321 | $14.44 | 40,321 (Direct) | View |
| 2007-05-01 Option Award |
2007-05-02 3:17 pm | 2008-03-28 2013-03-28 | Altus Pharmaceuticals Inc. | ALTU | FUCHS RENATO (SVP, Manufacturing & Tech Ops) | 40,321 | $14.44 | 40,321 (Direct) | View |
| 2006-01-31 Purchase | 2006-11-15 4:03 pm | N/A N/A | Altus Pharmaceuticals Inc. | ALTU | NOMURA INTERNATIONAL PLC Nomura Phase4 Ventures LP Nomura Phase4 Ventures LTD Nomura Phase4 Ventures GP LTD (Shareholder) | 2,317,639 | $0 | 0 (Direct) |
View |
| 2006-01-31 Purchase |
2006-11-15 4:03 pm |
N/A N/A | Altus Pharmaceuticals Inc. | ALTU | NOMURA INTERNATIONAL PLC Nomura Phase4 Ventures LP Nomura Phase4 Ventures LTD Nomura Phase4 Ventures GP LTD (Shareholder) | 1,140,570 | $0 | 0 (Indirect) |
View |
| 2006-01-31 Purchase | 2006-02-02 7:34 pm |
2001-09-26 2006-01-31 |
Altus Pharmaceuticals Inc. | ALTU | BRUM LYNNE H (Director) | 381,596 | $0 | 0 (Indirect) | View |
| 2006-01-31 Purchase | 2006-02-01 4:05 pm | N/A N/A |
Altus Pharmaceuticals Inc. | ALTU | NOMURA INTERNATIONAL PLC Nomura Phase4 Ventures LP (10% owner) | 2,317,639 | $0 | 0 (Direct) |
View |
| 2006-01-31 Purchase |
2006-02-01 4:05 pm |
N/A N/A |
Altus Pharmaceuticals Inc. | ALTU | NOMURA INTERNATIONAL PLC Nomura Phase4 Ventures LP (10% owner) | 1,140,570 | $0 | 0 (Indirect) | View |
|
© 2005-2009 SecForm4.Com All rights reserved. Archives: 2009 2008 2007 2006 2005 2004 ... Sat, 21 Nov 2009 21:58:11 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |